Rapid health technology evaluation of trastuzumab deruxtecan in the treatment of advanced or metastatic breast cancer

PDF(987 KB)
PDF(987 KB)
Chinese Journal of New Drugs ›› 2025, Vol. 34 ›› Issue (1) : 102-109. DOI: 10.20251/j.cnki.1003-3734.2025.01.015

Rapid health technology evaluation of trastuzumab deruxtecan in the treatment of advanced or metastatic breast cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 34(1): 102-109 https://doi.org/10.20251/j.cnki.1003-3734.2025.01.015

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(987 KB)

Accesses

Citation

Detail
Sections
Recommended
Total:
Copyright © Chinese Journal of New Drugs, All Rights Reserved.
Tel: 010-52722697 | 010-52723707
　 Powered by Beijing Magtech Co., Ltd.

/

〈 〉